stockowner

Merck, Schering-Plough Waste Money on Ineffective Allergy Drug

Most others countries discovered years earlier that Singulair has very minimal effects on asthmatics and even less with allergic rhinitis. There is common agreement that inhaled corticosteroids are the best defense for inflammatory mediators that are found in the lungs and nasal tissues of asthmatics and allergy patients. 95% of Mercks worldwide sales of Singulair occur in the US. The company was only able to effectively market this weak medication on the backs of parents who believe the hype that kids like to take medication that is easy to swallow. I will take an inhaler who's benefit is that it will save lives over a tablet that is easy to swallow. This is an example of effective marketing by Merck.